Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 852507, 9 pages
http://dx.doi.org/10.1155/2014/852507
Clinical Study

Chronic Kidney Disease Stage Is a Modulator on the Association between High-Sensitivity C-Reactive Protein and Coronary Vasospastic Angina

1Department of Nephrology, Chang Gung Memorial Hospital, Keelung 20401, Taiwan
2The Graduate Institute of Clinical Medical Sciences, Chang Gung University Medical College, Taoyuan 33302, Taiwan
3Department of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
4Department of Pediatrics, Taipei Medical University Hospital, Taipei 11031, Taiwan
5Laboratory of Epidemiology, Department of Health Care Management, Chang Gung University, Taoyuan 33302, Taiwan
6Department of Cardiology, Chang Gung Memorial Hospital, Keelung 20401, Taiwan

Received 10 December 2013; Accepted 22 January 2014; Published 5 March 2014

Academic Editors: C. Carbucicchio and H. Kitabata

Copyright © 2014 Heng-Jung Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. E. Mann, H. C. Gerstein, J. Poque, J. Bosch, and S. Yusuf, “Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial,” Annals of Internal Medicine, vol. 134, no. 8, pp. 629–636, 2001. View at Google Scholar · View at Scopus
  2. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Schiffrin, M. L. Lipman, and J. F. E. Mann, “Chronic kidney disease: effects on the cardiovascular system,” Circulation, vol. 116, no. 1, pp. 85–97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Goodkin, J. L. Bragg-Gresham, K. G. Koenig et al., “Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (dopps),” Journal of the American Society of Nephrology, vol. 14, no. 12, pp. 3270–3277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, “Clinical epidemiology of cardiovascular disease in chronic renal disease,” American Journal of Kidney Diseases, vol. 32, no. 5, pp. S112–S119, 1998. View at Google Scholar · View at Scopus
  6. A. J. Collins, B. Kasiske, S.-C. Chen et al., “Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States,” American Journal of Kidney Diseases, vol. 42, no. 6, supplement 5, pp. A5–A7, 2003. View at Google Scholar · View at Scopus
  7. S. Nishizawa, J. Shiraishi, S. Torii et al., “Intermediate fixed coronary artery stenosis at the site of ergonovine-provoked spasm as a predictor of long-term major adverse cardiac events of patients with coronary spastic angina,” Circulation Journal, vol. 73, no. 4, pp. 699–704, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Bory, D. Panagides, and L. Desfossez, “Coronary artery spasm in myocardial infarction,” The Lancet, vol. 342, no. 8868, p. 436, 1993. View at Google Scholar · View at Scopus
  9. E. Romagnoli and G. A. Lanza, “Acute myocardial infarction with normal coronary arteries: role of coronary artery spasm and arrhythmic complications,” International Journal of Cardiology, vol. 117, no. 1, pp. 3–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Igarashi, Y. Tamura, K. Suzuki et al., “Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease,” Coronary Artery Disease, vol. 4, no. 2, pp. 177–185, 1993. View at Google Scholar · View at Scopus
  11. M.-J. Hung, W.-J. Cherng, N.-I. Yang, C.-W. Cheng, and L.-F. Li, “Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease,” American Journal of Cardiology, vol. 96, no. 11, pp. 1484–1490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M.-J. Hung, W.-J. Cherng, C.-W. Cheng, and L.-F. Li, “Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease,” American Journal of Cardiology, vol. 97, no. 10, pp. 1429–1434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Itoh, Y. Mizuno, E. Harada, M. Yoshimura, H. Ogawa, and H. Yasue, “Coronary spasm is associated with chronic low-grade inflammation,” Circulation Journal, vol. 71, no. 7, pp. 1074–1078, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-J. Hung, L.-T. Kuo, C.-W. Cheng, C.-P. Chang, and W.-J. Cherng, “Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing,” American Journal of Cardiology, vol. 93, no. 5, pp. 620–624, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kato, M. Chmielewski, H. Honda et al., “Aspects of immune dysfunction in end-stage renal disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 5, pp. 1526–1533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. I. Parikh, S.-J. Hwang, M. G. Larson, D. Levy, and C. S. Fox, “Chronic kidney disease as a predictor of cardiovascular disease (from the framingham heart study),” American Journal of Cardiology, vol. 102, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Stevens, J. Coresh, H. I. Feldman et al., “Evaluation of the modification of diet in renal disease study equation in a large diverse population,” Journal of the American Society of Nephrology, vol. 18, no. 10, pp. 2749–2757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. W. J. Spruill, W. E. Wade, and H. H. Cobb III, “Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy,” American Journal of Health-System Pharmacy, vol. 64, no. 6, pp. 652–660, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M.-J. Hung, W.-J. Cherng, C.-W. Cheng, and N.-I. Yang, “Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease,” American Journal of Cardiology, vol. 95, no. 1, pp. 84–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Koga, S. Ikeda, T. Nakata et al., “Low glomerular filtration rate is associated with high prevalence of vasospastic angina,” Circulation Journal, vol. 75, no. 7, pp. 1691–1695, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Suzuki, S. Kawai, T. Aizawa et al., “Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions,” Journal of the American College of Cardiology, vol. 33, no. 1, pp. 198–205, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Marzilli, S. Goldstein, and M. G. Trivella, “Some clinical considerations regarding the relation of coronary vasospasm to coronary atherosclerosis: a hypothetical pathogenesis,” American Journal of Cardiology, vol. 45, no. 4, pp. 882–886, 1980. View at Google Scholar · View at Scopus
  23. Y. Ozaki, D. Keane, and P. W. Serruys, “Progression and regression of coronary stenosis in the long-term follow- up of vasospastic angina,” Circulation, vol. 92, no. 9, pp. 2446–2456, 1995. View at Google Scholar · View at Scopus
  24. R. Vanholder, G. Glorieux, and N. Lameire, “New insights in uremic toxicity,” Contributions to Nephrology, vol. 149, pp. 315–324, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Vanholder, R. de Smet, G. Glorieux et al., “Review on uremic toxins: classification, concentration, and interindividual variability,” Kidney International, vol. 63, no. 5, pp. 1934–1943, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Atoh, H. Itoh, and M. Haneda, “Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function,” Diabetes Research and Clinical Practice, vol. 83, no. 2, pp. 220–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. C. Raff, T. W. Meyer, and T. H. Hostetter, “New insights into uremic toxicity,” Current Opinion in Nephrology and Hypertension, vol. 17, no. 6, pp. 560–565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Ito, M. Terashima, H. Kaneda et al., “In vivo assessment of ergonovine-induced coronary artery spasm by 64-slice multislice computed tomography,” Circulation, vol. 5, pp. 226–232, 2012. View at Google Scholar
  29. H. Eddington, S. Sinha, E. Li et al., “Factors associated with vascular stiffness: cross-sectional analysis from the chronic renal insufficiency standards implementation study,” Nephron Clinical Practice, vol. 112, no. 3, pp. c190–c198, 2009. View at Publisher · View at Google Scholar · View at Scopus